Market Overview

Not Too Late to Buy Baxter, Jim Cramer Says

Related BAX
Benzinga's Top Upgrades, Downgrades For January 3, 2018
JPMorgan Diagnoses The MedTech Space: Stock Picks And Pans

Coming out of the Twittersphere late Thursday night: Jim Cramer offers advice to an investor who missed out on scooping up shares of Baxter International (NYSE: BAX) before the company announced a breakup into two separate, independent global healthcare companies.

Cramer, who correctly predicted Baxter's breakup, believes the stock can still be bought.

Shares of Baxter opened at $75.68, but closed at $72.80, finishing up 3.8 percent on Thursday.

Posted-In: Jim CramerAnalyst Color Jim Cramer Media Trading Ideas


Related Articles (BAX)

View Comments and Join the Discussion!